DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project

DXS INTERNATIONAL PLC (AQSE: DXSP)

ExpertCare featured in Innovate UK Research Project

DXS International plc ("DXS" or "the Company"), a leading provider of digital clinical decision support solutions, is thrilled to announce that its leading-edge digital health solution, ExpertCare, has been independently reviewed by the prestigious York Health Economics Consortium (YHEC) with results that confirm its powerful impact on both clinical outcomes and NHS cost-efficiency. 

Funded by DXS and Innovate UK and delivered in partnership with Health Innovation East, the evaluation assessed ExpertCare’s effectiveness in supporting medicines optimisation for patients with hypertension. The study, involving 2,484 patients across 13 UK GP practices, compared ExpertCare against standard hypertension review for GP practices. 

The evaluation found that ExpertCare delivers more effective hypertension control, reduces treatment variability, and is cost-saving in both the short and long term. 

The YHEC report concluded that: 

• ExpertCare significantly increases the number of patients with optimally managed hypertension. 

• For every £1 invested, ExpertCare returns £2.70 to the NHS. 

ExpertCare functions as an intelligent clinical decision support tool, streamlining data collection and generating treatment recommendations aligned with NICE guidelines—freeing up clinical time and improving outcomes at scale. 

David Immelman, CEO of DXS, commented: 

“We are incredibly proud of the results of this independent validation. It affirms our belief that ExpertCare has the potential to materially improve hypertension management across England, while reducing the cost burden on the NHS. These results highlight the real-world value of deploying ExpertCare nationally starting from year one.” 

For more information, please visit  

Contacts:

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

Attachment

• DXS - Announcement 10 July 2025

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• From Whitelist to the Next Meme Wave: Apeing Eyes the Best Meme Coin Spot While Snek and Pepe Hold Their Ground
• DREAMO and DREAMOSIS Bring the Collectible Character Into a New Physical-Digital World